Literature DB >> 2443640

Bupivacaine and lidocaine blockade of calcium-mediated slow action potentials in guinea pig ventricular muscle.

D E Coyle1, N Sperelakis.   

Abstract

The effects of bupivacaine and lidocaine on the slow-rising action potentials, induced by superfusion with high-K+ (26 mM) Tyrode's solution with 10(-6) M isoproterenol, were studied in guinea pig ventricular muscle. The concentrations of bupivacaine or lidocaine necessary to result in a 50% depression of the maximum upstroke velocity were about 10(-5) and 10(-4) M, respectively. The concentrations necessary to completely block the slow action potentials were about 10(-4) M for bupivacaine and 5 X 10(-4) M for lidocaine. The relative potencies of lidocaine to bupivacaine in abolishment of the slow action potentials are in the ratio of 1:5. These results suggest that local anesthetics do affect the slow Ca++ channel of ventricular muscle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443640

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Potentiation of cardiodepressive action among calcium antagonists from different classes: evidence for a mechanism at the single calcium channel level.

Authors:  S Braun; N Frey; S Herzig; C Hilbert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

Review 2.  Adverse effects and drug interactions associated with local and regional anaesthesia.

Authors:  M Naguib; M M Magboul; A H Samarkandi; M Attia
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

3.  Bupivacaine-induced slow-inward current inhibition: a voltage clamp study on frog atrial fibres.

Authors:  J E de La Coussaye; C Massé; B P Bassoul; J J Eledjam; J P Gagnol; A Sassine
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

4.  Myocardial uptake of lignocaine: pharmacokinetics and pharmacodynamics in the isolated perfused heart of the rabbit.

Authors:  J X Mazoit; J P Kantelip; E E Orhant; J M Talmant
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

5.  Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine.

Authors:  Robert W Gristwood
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Experimental myocardial preservation study of adding perfluorochemicals (FC43) in lidocaine cardioplegia.

Authors:  A Bito; K Inoue; M Asano; S Ando; T Takaba
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-05

7.  Optimal temperature of continuous lidocaine perfusion for the heart preservation.

Authors:  Mitsuru Asano; Koichi Inoue; Susumu Ando; Atsushi Bito; Yasuhiro Shiojiri; Makoto Yamada; Toshihiro Takaba
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-01

8.  Multi-modal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsion.

Authors:  Michael R Fettiplace; Kinga Lis; Richard Ripper; Katarzyna Kowal; Adrian Pichurko; Dominic Vitello; Israel Rubinstein; David Schwartz; Belinda S Akpa; Guy Weinberg
Journal:  J Control Release       Date:  2014-12-04       Impact factor: 9.776

9.  Transient inactivation of the ventral tegmental area selectively disrupts the expression of conditioned place preference for pup- but not cocaine-paired contexts.

Authors:  Katharine M Seip; Joan I Morrell
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

10.  Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion.

Authors:  Michael R Fettiplace; Katarzyna Kowal; Richard Ripper; Alexandria Young; Kinga Lis; Israel Rubinstein; Marcelo Bonini; Richard Minshall; Guy Weinberg
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.